Carla S Ceron Selected Research

salicylhydroxamic acid (SHAM)

10/2015	The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
2/2013	Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
5/2012	Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
1/2011	Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla S Ceron Research Topics

Disease

21	Hypertension (High Blood Pressure) 11/2023 - 05/2009
12	Renovascular Hypertension (Goldblatt Syndrome) 02/2018 - 05/2009
10	Vascular Remodeling 01/2022 - 05/2009
7	Hypertrophy 12/2015 - 01/2011
6	Fibrosis (Cirrhosis) 01/2021 - 02/2013
4	Cardiomegaly (Heart Hypertrophy) 10/2015 - 02/2013
3	Pre-Eclampsia (Preeclampsia) 01/2023 - 01/2022
2	Delayed Graft Function 01/2021 - 01/2015
2	Reperfusion Injury 01/2021 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2016
2	Thrombosis (Thrombus) 12/2013 - 07/2012
2	Pulmonary Embolism 12/2013 - 07/2012
1	Pathologic Processes 10/2021
1	Infections 03/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Sepsis (Septicemia) 04/2018
1	Vascular System Injuries 04/2018
1	Necrosis 01/2017
1	Heart Failure 01/2017
1	Inflammation (Inflammations) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2014
1	Right Ventricular Dysfunction 12/2013
1	Pulmonary Hypertension 12/2013
1	Hyperplasia 08/2013

Drug/Important Bio-Agent (IBA)

17	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2009
9	AntioxidantsIBA 01/2018 - 05/2009
6	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 08/2013
6	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2021 - 01/2011
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 05/2009
6	CollagenIBA 10/2015 - 05/2012
4	Protein Isoforms (Isoforms)IBA 10/2021 - 01/2015
4	Ethanol (Ethyl Alcohol)IBA 04/2018 - 01/2014
4	Eosine Yellowish-(YS) (Eosin)IBA 10/2015 - 02/2013
4	salicylhydroxamic acid (SHAM)IBA 10/2015 - 01/2011
4	Doxycycline (Periostat)FDA LinkGeneric 01/2014 - 05/2011
3	Nicotinamide PhosphoribosyltransferaseIBA 11/2023 - 01/2022
3	C.I. direct red 80IBA 10/2015 - 02/2013
3	Hematoxylin (Haematoxylon)IBA 08/2014 - 02/2013
3	Matrix Metalloproteinase InhibitorsIBA 01/2014 - 03/2012
3	tempolIBA 04/2013 - 05/2009
2	Renin InhibitorsIBA 02/2018 - 08/2013
2	aliskiren FDA Link 02/2018 - 08/2013
2	Losartan (Cozaar)FDA LinkGeneric 02/2018 - 08/2013
2	QuercetinIBA 01/2018 - 10/2010
2	Type 1 Angiotensin ReceptorIBA 04/2017 - 11/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 02/2013
2	Atorvastatin (Lipitor)FDA Link 12/2015 - 01/2013
2	Sildenafil Citrate (Viagra)FDA Link 12/2015 - 01/2013
2	Nebivolol FDA Link 08/2014 - 12/2013
2	Metoprolol (Toprol-XL)FDA LinkGeneric 08/2014 - 12/2013
2	3-nitrotyrosineIBA 08/2014 - 12/2013
2	APTIBA 12/2013 - 07/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2013 - 05/2012
2	ElastinIBA 08/2013 - 05/2012
2	NitritesIBA 01/2013 - 10/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 03/2012
1	CytokinesIBA 01/2022
1	EnzymesIBA 10/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2021
1	Interleukin-10 (Interleukin 10)IBA 03/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 02/2018
1	Angiotensin IIIBA 02/2018
1	dihydroethidiumIBA 02/2018
1	ReninIBA 02/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2018
1	FlavonoidsIBA 01/2018
1	GelatinasesIBA 10/2015
1	pyrrolidine dithiocarbamic acidIBA 10/2015
1	NF-kappa B (NF-kB)IBA 10/2015
1	prolinedithiocarbamate (PDTC)IBA 10/2015
1	S-NitrosothiolsIBA 10/2015
1	NitratesIBA 10/2015
1	Sodium NitriteIBA 10/2015
1	Dobutamine FDA LinkGeneric 12/2013
1	Superoxides (Superoxide)IBA 12/2013
1	Thiobarbituric Acid Reactive SubstancesIBA 12/2013
1	Mitogen-Activated Protein Kinase 3IBA 08/2013
1	Troponin IIBA 07/2012
1	TetracyclinesIBA 03/2012
1	Calcimycin (A23187)IBA 03/2012
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2011
1	Tissue Inhibitor of Metalloproteinase-2IBA 08/2011
1	Nimodipine (Modus)FDA LinkGeneric 01/2011
1	DihydropyridinesIBA 01/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2011
1	lercanidipineIBA 01/2011
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2011

Therapy/Procedure

12	Surgical Instruments (Clip) 02/2018 - 05/2009
2	Therapeutics 01/2023 - 10/2015
1	Kidney Transplantation 01/2015
1	Transplantation 01/2015
1	Aftercare (After-Treatment) 08/2014